Clinical Trial

A Study of Multilocus Methylation Abnormalities in Subjects With Imprinting Disorders

Study acronym: ImprintiNG
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Imprinting disorders may be caused by epimutations. Some subjects exhibit methylation abnormalities in several regions subject to imprinting, a condition known as multilocus imprinting disorder (MLID). The prevalence of MLID is unknown, due to variations in the methodologies used (including technique employed and number of regions studied). The phenotypic consequences of MLID are also poorly understood. Studying the methylation of all the imprinted regions would make it possible to determine the prevalence of MLID as well as its clinical consequences.
Trial Details
NCT Number NCT07497477
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Imprinting Disorder, MLID, Multi-locus Imprinting Disturbance, Differentially Methylated Regions, Molecular Diagnosis
Enrollment 96 participants
Start Date 2026-04
Primary Completion 2028-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-27